nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—prostate gland—urinary bladder cancer	0.0273	0.192	CbGeAlD
Etomidate—SLC2A1—epithelium—urinary bladder cancer	0.02	0.141	CbGeAlD
Etomidate—SLC2A1—renal system—urinary bladder cancer	0.0186	0.131	CbGeAlD
Etomidate—CYP11B2—renal system—urinary bladder cancer	0.0159	0.112	CbGeAlD
Etomidate—SLC2A1—female reproductive system—urinary bladder cancer	0.0149	0.105	CbGeAlD
Etomidate—Pseudoephedrine—IL2—urinary bladder cancer	0.0147	0.642	CrCbGaD
Etomidate—SLC2A1—vagina—urinary bladder cancer	0.0135	0.0945	CbGeAlD
Etomidate—SLC2A1—lymph node—urinary bladder cancer	0.00871	0.0612	CbGeAlD
Etomidate—CYP19A1—prostate gland—urinary bladder cancer	0.00862	0.0606	CbGeAlD
Etomidate—CYP11B2—lymph node—urinary bladder cancer	0.00746	0.0524	CbGeAlD
Etomidate—Pseudoephedrine—TNF—urinary bladder cancer	0.00495	0.217	CrCbGaD
Etomidate—CYP19A1—female reproductive system—urinary bladder cancer	0.00471	0.0331	CbGeAlD
Etomidate—Fenoprofen—PTGS2—urinary bladder cancer	0.00323	0.141	CrCbGaD
Etomidate—CYP19A1—lymph node—urinary bladder cancer	0.00275	0.0193	CbGeAlD
Etomidate—Hypoxia—Thiotepa—urinary bladder cancer	0.00203	0.0641	CcSEcCtD
Etomidate—Hypoxia—Gemcitabine—urinary bladder cancer	0.00171	0.0539	CcSEcCtD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00127	0.00158	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CXCL8—urinary bladder cancer	0.00126	0.00157	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00125	0.00155	CbGpPWpGaD
Etomidate—Laryngospasm—Etoposide—urinary bladder cancer	0.00124	0.0392	CcSEcCtD
Etomidate—CYP11B1—Corticotropin-releasing hormone—IL2—urinary bladder cancer	0.00121	0.00151	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TYMP—urinary bladder cancer	0.00119	0.00148	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00116	0.00144	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—SRC—urinary bladder cancer	0.00112	0.00139	CbGpPWpGaD
Etomidate—Respiratory failure—Gemcitabine—urinary bladder cancer	0.0011	0.0349	CcSEcCtD
Etomidate—Apnoea—Etoposide—urinary bladder cancer	0.00109	0.0345	CcSEcCtD
Etomidate—CYP11B2—Metabolism—GSTZ1—urinary bladder cancer	0.00108	0.00135	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NAT2—urinary bladder cancer	0.00108	0.00134	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—HRAS—urinary bladder cancer	0.00106	0.00132	CbGpPWpGaD
Etomidate—Pain—Carboplatin—urinary bladder cancer	0.00105	0.0332	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00105	0.00131	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ENO2—urinary bladder cancer	0.00103	0.00128	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTO2—urinary bladder cancer	0.00103	0.00128	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NAT1—urinary bladder cancer	0.00103	0.00128	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00101	0.00126	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00101	0.00126	CbGpPWpGaD
Etomidate—Hiccups—Cisplatin—urinary bladder cancer	0.00101	0.0319	CcSEcCtD
Etomidate—SLC2A1—Disease—RBX1—urinary bladder cancer	0.000975	0.00121	CbGpPWpGaD
Etomidate—Hypertension—Mitomycin—urinary bladder cancer	0.000967	0.0305	CcSEcCtD
Etomidate—GABRB2—Orphan transporters—CREBBP—urinary bladder cancer	0.000967	0.0012	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—UGT2B7—urinary bladder cancer	0.000941	0.00117	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTZ1—urinary bladder cancer	0.000935	0.00116	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—RRM2—urinary bladder cancer	0.00093	0.00116	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000929	0.00116	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000916	0.00114	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NAT1—urinary bladder cancer	0.000886	0.0011	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTO2—urinary bladder cancer	0.000886	0.0011	CbGpPWpGaD
Etomidate—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	0.000884	0.0011	CbGpPWpGaD
Etomidate—Hypoxia—Methotrexate—urinary bladder cancer	0.000873	0.0276	CcSEcCtD
Etomidate—SLC2A1—Disease—JAG1—urinary bladder cancer	0.000873	0.00109	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000872	0.00109	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000865	0.00108	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ENO2—urinary bladder cancer	0.000861	0.00107	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HPGDS—urinary bladder cancer	0.000861	0.00107	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000853	0.00106	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP4B1—urinary bladder cancer	0.000847	0.00105	CbGpPWpGaD
Etomidate—Vomiting—Valrubicin—urinary bladder cancer	0.000844	0.0266	CcSEcCtD
Etomidate—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000838	0.00104	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTT1—urinary bladder cancer	0.000835	0.00104	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—UGT2B7—urinary bladder cancer	0.000811	0.00101	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC19A1—urinary bladder cancer	0.0008	0.000996	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000795	0.00099	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000784	0.000976	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000782	0.000974	CbGpPWpGaD
Etomidate—Pain—Mitomycin—urinary bladder cancer	0.000782	0.0247	CcSEcCtD
Etomidate—CYP11B2—Metabolism—PRSS3—urinary bladder cancer	0.000779	0.00097	CbGpPWpGaD
Etomidate—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000773	0.000962	CbGpPWpGaD
Etomidate—Hyperventilation—Epirubicin—urinary bladder cancer	0.000754	0.0238	CcSEcCtD
Etomidate—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000747	0.00093	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000732	0.000912	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP4B1—urinary bladder cancer	0.00073	0.000909	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000699	0.00087	CbGpPWpGaD
Etomidate—Hyperventilation—Doxorubicin—urinary bladder cancer	0.000698	0.022	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000696	0.000866	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NQO1—urinary bladder cancer	0.000694	0.000864	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000693	0.000863	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC19A1—urinary bladder cancer	0.000689	0.000858	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000683	0.00085	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PRSS3—urinary bladder cancer	0.000672	0.000836	CbGpPWpGaD
Etomidate—Apnoea—Methotrexate—urinary bladder cancer	0.000654	0.0207	CcSEcCtD
Etomidate—SLC2A1—Disease—NCOR1—urinary bladder cancer	0.000635	0.000791	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000625	0.000778	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TYMP—urinary bladder cancer	0.000623	0.000776	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000605	0.000753	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000603	0.00075	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000598	0.000745	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERCC2—urinary bladder cancer	0.000597	0.000744	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000597	0.000743	CbGpPWpGaD
Etomidate—Vomiting—Mitomycin—urinary bladder cancer	0.000581	0.0184	CcSEcCtD
Etomidate—SLC2A1—Metabolism—GSTP1—urinary bladder cancer	0.000579	0.000721	CbGpPWpGaD
Etomidate—Arrhythmia—Thiotepa—urinary bladder cancer	0.000578	0.0183	CcSEcCtD
Etomidate—Respiratory failure—Methotrexate—urinary bladder cancer	0.000565	0.0178	CcSEcCtD
Etomidate—CYP11B2—Metabolism—NAT2—urinary bladder cancer	0.000563	0.000702	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—urinary bladder cancer	0.000562	0.000699	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TERT—urinary bladder cancer	0.00056	0.000697	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000559	0.000696	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000538	0.000671	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TYMS—urinary bladder cancer	0.000538	0.00067	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TYMP—urinary bladder cancer	0.000537	0.000669	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTM1—urinary bladder cancer	0.000532	0.000663	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NCOR1—urinary bladder cancer	0.000532	0.000663	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.00053	0.00066	CbGpPWpGaD
Etomidate—Hiccups—Epirubicin—urinary bladder cancer	0.000519	0.0164	CcSEcCtD
Etomidate—Bradycardia—Cisplatin—urinary bladder cancer	0.000517	0.0163	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000516	0.000642	CbGpPWpGaD
Etomidate—SLC2A1—Disease—FGFR3—urinary bladder cancer	0.000514	0.00064	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GPX1—urinary bladder cancer	0.00051	0.000634	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000504	0.000628	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.000502	0.000625	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.000502	0.000625	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ERCC2—urinary bladder cancer	0.0005	0.000623	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000494	0.000615	CbGpPWpGaD
Etomidate—Convulsion—Thiotepa—urinary bladder cancer	0.000488	0.0154	CcSEcCtD
Etomidate—Hypertension—Thiotepa—urinary bladder cancer	0.000486	0.0154	CcSEcCtD
Etomidate—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000486	0.0154	CcSEcCtD
Etomidate—CYP11B2—Metabolism—RRM2—urinary bladder cancer	0.000486	0.000606	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NAT2—urinary bladder cancer	0.000486	0.000605	CbGpPWpGaD
Etomidate—Hiccups—Doxorubicin—urinary bladder cancer	0.00048	0.0152	CcSEcCtD
Etomidate—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000478	0.0151	CcSEcCtD
Etomidate—SLC2A1—Metabolism—MTHFR—urinary bladder cancer	0.00047	0.000586	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000461	0.000574	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000459	0.000572	CbGpPWpGaD
Etomidate—Arrhythmia—Cisplatin—urinary bladder cancer	0.000453	0.0143	CcSEcCtD
Etomidate—CYP11B2—Metabolism—ENO2—urinary bladder cancer	0.00045	0.000561	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HPGDS—urinary bladder cancer	0.00045	0.000561	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000449	0.000559	CbGpPWpGaD
Etomidate—Tachycardia—Thiotepa—urinary bladder cancer	0.000449	0.0142	CcSEcCtD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000448	0.000558	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000444	0.000552	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CREBBP—urinary bladder cancer	0.000437	0.000545	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—urinary bladder cancer	0.000437	0.000544	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000434	0.00054	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00043	0.000536	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—RRM2—urinary bladder cancer	0.000419	0.000522	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000414	0.000515	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000414	0.000515	CbGpPWpGaD
Etomidate—Hypertension—Gemcitabine—urinary bladder cancer	0.000409	0.0129	CcSEcCtD
Etomidate—Convulsion—Fluorouracil—urinary bladder cancer	0.000404	0.0128	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000403	0.000502	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000399	0.000497	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RHOA—urinary bladder cancer	0.000396	0.000493	CbGpPWpGaD
Etomidate—Pain—Thiotepa—urinary bladder cancer	0.000393	0.0124	CcSEcCtD
Etomidate—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000391	0.000486	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HPGDS—urinary bladder cancer	0.000388	0.000483	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO2—urinary bladder cancer	0.000388	0.000483	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000386	0.000481	CbGpPWpGaD
Etomidate—Convulsion—Cisplatin—urinary bladder cancer	0.000383	0.0121	CcSEcCtD
Etomidate—SLC2A1—Metabolism—PPARG—urinary bladder cancer	0.000381	0.000475	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000381	0.000474	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00038	0.000474	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—urinary bladder cancer	0.000376	0.000469	CbGpPWpGaD
Etomidate—Tachycardia—Fluorouracil—urinary bladder cancer	0.000371	0.0117	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000371	0.000462	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CREBBP—urinary bladder cancer	0.000366	0.000456	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—urinary bladder cancer	0.000366	0.000456	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.000366	0.000455	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NQO1—urinary bladder cancer	0.000363	0.000452	CbGpPWpGaD
Etomidate—Hypotension—Gemcitabine—urinary bladder cancer	0.000361	0.0114	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.00036	0.000449	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—urinary bladder cancer	0.000358	0.000446	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNA2—urinary bladder cancer	0.000356	0.000443	CbGpPWpGaD
Etomidate—Hypotension—Fluorouracil—urinary bladder cancer	0.000355	0.0112	CcSEcCtD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000355	0.000442	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000352	0.000439	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000352	0.000439	CbGpPWpGaD
Etomidate—Tachycardia—Cisplatin—urinary bladder cancer	0.000352	0.0111	CcSEcCtD
Etomidate—Convulsion—Etoposide—urinary bladder cancer	0.000351	0.0111	CcSEcCtD
Etomidate—Hypertension—Etoposide—urinary bladder cancer	0.000349	0.011	CcSEcCtD
Etomidate—Hypotension—Cisplatin—urinary bladder cancer	0.000337	0.0106	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000333	0.000415	CbGpPWpGaD
Etomidate—Pain—Gemcitabine—urinary bladder cancer	0.000331	0.0104	CcSEcCtD
Etomidate—Pain—Fluorouracil—urinary bladder cancer	0.000325	0.0103	CcSEcCtD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000325	0.000404	CbGpPWpGaD
Etomidate—Tachycardia—Etoposide—urinary bladder cancer	0.000322	0.0102	CcSEcCtD
Etomidate—SLC2A1—Disease—CDKN1A—urinary bladder cancer	0.000313	0.00039	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NQO1—urinary bladder cancer	0.000313	0.00039	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTEN—urinary bladder cancer	0.000312	0.000389	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000309	0.000385	CbGpPWpGaD
Etomidate—Hypotension—Etoposide—urinary bladder cancer	0.000309	0.00975	CcSEcCtD
Etomidate—Pain—Cisplatin—urinary bladder cancer	0.000308	0.00974	CcSEcCtD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000307	0.000383	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000307	0.000382	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000306	0.000381	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000305	0.00038	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000304	0.000379	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000304	0.000378	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—urinary bladder cancer	0.000303	0.000377	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—urinary bladder cancer	0.0003	0.000374	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—urinary bladder cancer	0.000298	0.000371	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000296	0.000368	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000293	0.000365	CbGpPWpGaD
Etomidate—Vomiting—Thiotepa—urinary bladder cancer	0.000292	0.00923	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000292	0.000364	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SRC—urinary bladder cancer	0.00029	0.000361	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000284	0.000354	CbGpPWpGaD
Etomidate—Pain—Etoposide—urinary bladder cancer	0.000282	0.00892	CcSEcCtD
Etomidate—CYP11B2—Metabolism—TYMS—urinary bladder cancer	0.000282	0.000351	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—urinary bladder cancer	0.000278	0.000347	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NCOR1—urinary bladder cancer	0.000278	0.000347	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.000275	0.000343	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC4—urinary bladder cancer	0.000274	0.000341	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000268	0.000333	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000267	0.000332	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GPX1—urinary bladder cancer	0.000266	0.000332	CbGpPWpGaD
Etomidate—Bradycardia—Epirubicin—urinary bladder cancer	0.000265	0.00838	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000265	0.00033	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ERCC2—urinary bladder cancer	0.000262	0.000326	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—urinary bladder cancer	0.000262	0.000326	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—urinary bladder cancer	0.000261	0.000325	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—urinary bladder cancer	0.00026	0.000323	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—urinary bladder cancer	0.000254	0.000316	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAU—urinary bladder cancer	0.000253	0.000314	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000252	0.000314	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—urinary bladder cancer	0.000249	0.000311	CbGpPWpGaD
Etomidate—Vomiting—Gemcitabine—urinary bladder cancer	0.000246	0.00777	CcSEcCtD
Etomidate—CYP11B2—Metabolism—MTHFR—urinary bladder cancer	0.000246	0.000306	CbGpPWpGaD
Etomidate—Bradycardia—Doxorubicin—urinary bladder cancer	0.000245	0.00775	CcSEcCtD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000244	0.000304	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000243	0.000303	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TYMS—urinary bladder cancer	0.000243	0.000302	CbGpPWpGaD
Etomidate—Vomiting—Fluorouracil—urinary bladder cancer	0.000242	0.00764	CcSEcCtD
Etomidate—SLC2A1—Disease—KRAS—urinary bladder cancer	0.00024	0.000299	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NCOR1—urinary bladder cancer	0.00024	0.000299	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—urinary bladder cancer	0.00024	0.000299	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000238	0.000296	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000236	0.000294	CbGpPWpGaD
Etomidate—Arrhythmia—Epirubicin—urinary bladder cancer	0.000233	0.00735	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—GLI1—urinary bladder cancer	0.00023	0.000286	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GPX1—urinary bladder cancer	0.00023	0.000286	CbGpPWpGaD
Etomidate—Vomiting—Cisplatin—urinary bladder cancer	0.000229	0.00724	CcSEcCtD
Etomidate—CYP11B1—Metabolism—ERCC2—urinary bladder cancer	0.000225	0.000281	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.00022	0.000274	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.00022	0.000274	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000219	0.000272	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000216	0.000269	CbGpPWpGaD
Etomidate—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000215	0.0068	CcSEcCtD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000213	0.000266	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000213	0.000266	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—urinary bladder cancer	0.000212	0.000264	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00021	0.000262	CbGpPWpGaD
Etomidate—Convulsion—Methotrexate—urinary bladder cancer	0.00021	0.00663	CcSEcCtD
Etomidate—Vomiting—Etoposide—urinary bladder cancer	0.00021	0.00663	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—CREBBP—urinary bladder cancer	0.000208	0.000259	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—urinary bladder cancer	0.000206	0.000256	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—urinary bladder cancer	0.000205	0.000255	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—urinary bladder cancer	0.000204	0.000254	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—urinary bladder cancer	0.000199	0.000248	CbGpPWpGaD
Etomidate—Convulsion—Epirubicin—urinary bladder cancer	0.000197	0.00621	CcSEcCtD
Etomidate—Hypertension—Epirubicin—urinary bladder cancer	0.000196	0.00619	CcSEcCtD
Etomidate—CYP11B2—Metabolism—CREBBP—urinary bladder cancer	0.000192	0.000239	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000189	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RHOA—urinary bladder cancer	0.000188	0.000235	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—urinary bladder cancer	0.000187	0.000233	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000185	0.00023	CbGpPWpGaD
Etomidate—Hypotension—Methotrexate—urinary bladder cancer	0.000185	0.00584	CcSEcCtD
Etomidate—Convulsion—Doxorubicin—urinary bladder cancer	0.000182	0.00574	CcSEcCtD
Etomidate—Hypertension—Doxorubicin—urinary bladder cancer	0.000181	0.00572	CcSEcCtD
Etomidate—Tachycardia—Epirubicin—urinary bladder cancer	0.000181	0.00571	CcSEcCtD
Etomidate—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000177	0.000221	CbGpPWpGaD
Etomidate—Hypotension—Epirubicin—urinary bladder cancer	0.000173	0.00546	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000172	0.000214	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—urinary bladder cancer	0.000172	0.000214	CbGpPWpGaD
Etomidate—Pain—Methotrexate—urinary bladder cancer	0.000169	0.00534	CcSEcCtD
Etomidate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000167	0.00528	CcSEcCtD
Etomidate—CYP11B1—Metabolism—CREBBP—urinary bladder cancer	0.000165	0.000206	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—urinary bladder cancer	0.000164	0.000204	CbGpPWpGaD
Etomidate—Hypotension—Doxorubicin—urinary bladder cancer	0.00016	0.00506	CcSEcCtD
Etomidate—Pain—Epirubicin—urinary bladder cancer	0.000158	0.005	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—IL2—urinary bladder cancer	0.000158	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RBX1—urinary bladder cancer	0.000157	0.000196	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—urinary bladder cancer	0.000157	0.000195	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00015	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSC1—urinary bladder cancer	0.000148	0.000184	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000148	0.000184	CbGpPWpGaD
Etomidate—Pain—Doxorubicin—urinary bladder cancer	0.000147	0.00463	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000143	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—urinary bladder cancer	0.000142	0.000177	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—JAG1—urinary bladder cancer	0.000141	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SRC—urinary bladder cancer	0.000138	0.000172	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000137	0.000171	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—urinary bladder cancer	0.000137	0.00017	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000136	0.000169	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000136	0.000169	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—urinary bladder cancer	0.000135	0.000168	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—urinary bladder cancer	0.00013	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.00013	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000128	0.000159	CbGpPWpGaD
Etomidate—Vomiting—Methotrexate—urinary bladder cancer	0.000126	0.00397	CcSEcCtD
Etomidate—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.00012	0.00015	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000119	0.000148	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—urinary bladder cancer	0.000118	0.000147	CbGpPWpGaD
Etomidate—Vomiting—Epirubicin—urinary bladder cancer	0.000118	0.00372	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—KRAS—urinary bladder cancer	0.000114	0.000142	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—S100B—urinary bladder cancer	0.000114	0.000142	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—urinary bladder cancer	0.000112	0.00014	CbGpPWpGaD
Etomidate—Vomiting—Doxorubicin—urinary bladder cancer	0.000109	0.00344	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—RHOA—urinary bladder cancer	0.000108	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000105	0.00013	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCOR1—urinary bladder cancer	0.000103	0.000128	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—urinary bladder cancer	0.000102	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—urinary bladder cancer	9.99e-05	0.000124	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—urinary bladder cancer	9.74e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—urinary bladder cancer	9.71e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—urinary bladder cancer	9.5e-05	0.000118	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	9.36e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—urinary bladder cancer	9.07e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TERT—urinary bladder cancer	9.04e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGFR3—urinary bladder cancer	8.3e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ESR1—urinary bladder cancer	8.06e-05	0.0001	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	7.66e-05	9.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CREBBP—urinary bladder cancer	7.06e-05	8.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—urinary bladder cancer	6.98e-05	8.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—urinary bladder cancer	6.94e-05	8.64e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—urinary bladder cancer	6.68e-05	8.32e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—urinary bladder cancer	6.56e-05	8.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RHOA—urinary bladder cancer	6.39e-05	7.96e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—urinary bladder cancer	6.37e-05	7.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—urinary bladder cancer	5.92e-05	7.37e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	5.61e-05	6.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	5.57e-05	6.94e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	5.36e-05	6.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	5.23e-05	6.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	5.07e-05	6.32e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	5.06e-05	6.29e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	5.04e-05	6.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	4.81e-05	5.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	4.68e-05	5.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	4.19e-05	5.22e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	4.1e-05	5.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	3.87e-05	4.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	3.44e-05	4.29e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	3.29e-05	4.1e-05	CbGpPWpGaD
